Efficacy, safety and tolerability of Atorvastatin in patients with Relapsing-remitting multiple sclerosis in treAtment with INterferoN-beta (ARIANNA): a multicentre, randomised, double-blind, placebo-controlled, parallel-group-study

|< < > >|

Export to BibTeX Export to EndNote

Efficacy, safety and tolerability of Atorvastatin in patients with Relapsing-remitting multiple sclerosis in treAtment with INterferoN-beta (ARIANNA): a multicentre, randomised, double-blind, placebo-controlled, parallel-group-study (72 views)

Brescia Morra V, Alfano B, Lanzillo R, Quarantelli M, Comerci M, Marini S, Vacca G, Amato MP, Trojano M, Brunetti A, Pozzilli C

Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2012 Oct; 18: 197-197.

Abstract
Not available.

Affiliations ▼

*** IBB - CNR Affiliation

University of Naples Federico II

Consiglio Nazionale delle Ricerche (CNR)

University of Florence

Sapienza University Rome

Details ▼

Impact factor: 4.863, 5-year impact factor: 4.276

Paper type: Abstract, Conference,

Keywords: Not available.

Url: Not available.

References ▼

Not available.

Related activities ▼

Evaluation of new molecular probes by preclinical imaging. (270 views)

Related papers ▼

Advances in molecular preclinical therapy mediated by imaging (public domain) (1 views)

Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers (public domain) (12 views)

Assessment of scanner performance and normalization of estimated relaxation rate values (restricted access) (57 views)

EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision (restricted access) (73 views)

Effects of a novel Nodal-targeting monoclonal antibody in melanoma (restricted access) (52 views)

Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target Antigen (public domain) (89 views)

Surgical Management of Pediatric Vesicoureteral Reflux: A Comparative Study Between Endoscopic, Laparoscopic, and Open Surgery (public domain) (28 views)

Related bibliography ▼

Advanced search

<=2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 ALL YEARS

End of page

Copy&Paste Friendly Export all to BibTeX Export all to EndNote

Sort by: date ▼▲ title ▲ ▼ journal ▲ ▼ authors ▲ ▼ impact factor ▲ ▼

* Efficacy, Safety And Tolerability Of Atorvastatin In Patients With Relapsing-Remitting Multiple Sclerosis In Treatment With Interferon-Beta (arianna): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group-Study, Lyon. France (84 views)
Brescia Morra V, Alfano B, Lanzillo R, Quarantelli M, Comerci M, Marini S, Vacca G, Amato MP, Trojano M, Brunetti A, Pozzilli C
Proceedings Of The 23rd Ectrims Meeting Lyon France, 2012 Oct 10; AbstractBook: 477-477.

View Export to BibTeX Export to EndNote Upload PDF

* Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: A longitudinal controlled trial of combination therapy (37 views)
Lanzillo R, Orefice G, Quarantelli M, Rinaldi C, Prinster A, Ventrella G, Spitaleri D, Lus G, Vacca G, Carotenuto B, Salvatore E, Brunetti A, Tedeschi G, Brescia Morra V
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2010 Apr; 16(4): 450-454.

View Export to BibTeX Export to EndNote Upload PDF

2 Records (1 excluding Abstracts and Conferences).
Total impact factor: 4.863 (4.863 excluding Abstracts and Conferences).
Total 5-year impact factor: 4.276 (4.276 excluding Abstracts and Conferences).

Copy&Paste Friendly Export all to BibTeX Export all to EndNote

Top

Your bibliography query: (([btitle, keywords, abstract] EFFICACY AND [btitle, keywords, abstract] SAFETY AND [btitle, keywords, abstract] TOLERABILITY AND [btitle, keywords, abstract] ATORVASTATIN AND [btitle, keywords, abstract] PATIENTS AND [btitle, keywords, abstract] WITH AND [btitle, keywords, abstract] RELAPSING)) AND NOT [id] = 48272

Last modified by Marco Comerci on Thursday 19 March 2015, 12:24:03
72 views. Last viewed on Wednesday 12 July 2017, 1:07:35